Impact of Race on Outcome after Definitive Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

Cancer

Volumn 98, Issue 11, 2003, Pages 2467-2472

  Al Othman, Majid O F ^a   Morris, Christopher G ^a   Logan, Henrietta L ^b   Hinerman, Russell W ^a   Amdur, Robert J ^a   Mendenhall, William M ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c NONE   (United States)

Author keywords

Absolute survival; Cause specific survival; Control rates; Radiotherapy; Recurrence

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CAUCASIAN; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; NEGRO; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0345275883     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11822     Document Type: Article

References (31)

1. Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. Philadelphia: JB Lippincott, 1994.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
3. Roach M III, Alexander M, Coleman JL. The prognostic significance of race and survival from laryngeal carcinoma. J Natl Med Assoc. 1992;84:668-674.
4. Moore RJ, Doherty DA, Do KA, Chamberlain RM, Khuri FR. Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health. 2001;6:165-177.
5. Murdock JM, Gluckman JL. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate? Cancer. 2001;91:279-283.
6. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2 NO squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19:4029-4036.
7. Fleming ID, Coooper JS, Hensen DE, et al. AJCC cancer staging manual (5th edition). Philadelphia: Lippincott-Raven, 1998.
8. Levitt SH, Potish RA, Khan FM, Perez CA. Levitt and Tapley's technological basis of radiation therapy: clinical applications. Baltimore: Lippincott Williams & Wilkins, 1999.
9. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck. 1993;15:87-96.
10. Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2002;24:1012-1018.
11. SAS Institute Inc. SAS onlinedoc 9. Cary, NC: SAS Institute, 2003.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
14. Arbes SJ Jr., Olshan AF, Caplan DL, Schoenbach VJ, Slade GD, Symons MJ. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control. 1999;10:513-523.
15. Caplan DJ, Hertz-Picciotto I. Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent. 1998;58:36-43.
16. Goldberg HI, Lockwood SA, Wyatt SW, Crossett LS. Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer. 1994;74:565-572.
17. Mendenhall WM, Riggs CE, Amdur RJ, Hinerman RW, Villaret DB. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Laryngoscope. 2003;113:546-551.
18. Hoffman HT, Kamell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:951-962.
19. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585-1592.
20. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services-a review of barriers to quality care. Cancer. 1999;86:2378-2390.
21. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
22. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck. 2001;23:147-159.
23. Bockmuhl U, Petersen S, Schmidt S, et al. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res. 1997;57:5213-5216.
24. Cooper RS, Kaufman JS, Ward R. Race and genomics. N Engl J Med. 2003;348:1166-1170.
25. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170-1175.
26. Hall SF, Groome PA, Rothwell D. The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck. 2000;22:317-322.
27. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997;8:621-628.
28. Kington RS, Smith JP. Socioeconomic status and racial and ethnic differences in functional status associated with chronic diseases. Am J Public Health. 1997;87:805-810.
29. Johnson JT. Proposal of standardization on screening tests for detection of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63:256-258.
30. Kim ES, Glisson BS. Treatment of metastatic head and neck cancer: chemotherapy and novel agents. Cancer Treat Res. 2003;114:295-314.
31. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol. 2000;18:1458-1464.